Short-term budesonide transnasal nebulization effectively and safely treated patients with chronic rhinosinusitis with nasal polyps when compared with placebo, according to study results. In a double ...
Sept. 5, 2003 — Caregivers of children treated with once or twice daily budesonide reported fewer limitations in daily activities and emotional functioning than caregivers of children treated with ...
August 22, 2008 — A budesonide/formoterol (Symbicort, AstraZeneca) pressurized metered-dose inhaler (pMDI) showed safety and better asthma control versus budesonide alone, according to the results of ...
This week, Dr Ray O’Connor takes a look at recent clinical articles on the management of asthma, and what environmental ...
The inclusion of BATURA study results in the US prescribing information builds upon the previous MANDALA Phase III trial in adult patients with moderate to severe asthma. 3 The MANDALA and BATURA ...
JERUSALEM--(BUSINESS WIRE)--Mar. 9, 2016-- Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) today announced the launch of the generic equivalent to Pulmicort Respules®1 (budesonide inhalation ...
Budesonide (micronized) 90mcg/inh, 180mcg/inh; dry pwd for inhalation. Pulmicort Flexhaler is available as a dry powder for inhalation containing budesonide in the following 2 strengths: 90 mcg and ...
Two drugs are better than one when it comes to stopping asthma attacks in progress, a new clinical trial has found. The study, of more than 3,100 asthma patients, found that a two-drug "rescue" ...
Inhaled steroids reduce and prevent inflammation, swelling, and mucus build-up in your airways and lungs to help prevent asthma attacks and help you breathe easier. But not everyone with asthma needs ...
AstraZeneca today announced that the United States District Court for the District of New Jersey ruled that AstraZeneca's US Patent No. 6,598,603 ("the '603 patent"), protecting PULMICORT RESPULES in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback